We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oncorus Inc | NASDAQ:ONCR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.12055 | 0.13 | 0.091 | 0 | 01:00:00 |
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Arkin Bio Ventures Limited Partnership
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER:
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER:
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
4.11%*
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON:
|
|
|
||
PN
|
|
|
|||
|
|
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Arkin Bio Venture Partners, Ltd.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER:
|
|
|
|
0
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER:
|
|
|
||
0
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
4.11%*
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON:
|
|
|
||
CO
|
|
|
|||
|
|
1
|
NAMES OF REPORTING PERSONS:
|
|
|
||
Moshe Arkin
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
|
||||
(a)☐
|
|||||
(b)☒
|
|
|
|||
3
|
SEC USE ONLY:
|
|
|
||
|
|
|
|||
|
|
||||
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION:
Israel |
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER:
|
|
|
|
1,441,388
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER:
|
|
|
||
1,441,388
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER:
|
|
|
||
1,067,093
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
|
|
||
2,508,481
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
|
|
|
||
☐
|
|
|
|||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
|
|
|
||
9.66%*
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON:
|
|
|
||
IN
|
|
|
|||
|
|
Item 1. (a)
|
Name of
Issuer:
|
(b) |
Address of Issuer's Principal Executive Offices:
|
Item 2. (a) |
Name of Person Filing:
|
(b) |
Address of Principal Business Office:
|
(c) |
Citizenship or Place of Incorporation:
|
(d) |
Title of Class of Securities:
|
(e) |
CUSIP Number:
|
Item 3. |
Not applicable.
|
Item 4. |
Ownership:
|
(a) |
Amount beneficially owned:
|
• |
1,067,093 shares of Common Stock, representing a total of 4.11% of the total shares of Common Stock outstanding, are held directly by Arkin Bio Ventures Limited
Partnership.
|
• |
1,441,388shares of Common Stock, representing a total of 5.55% of the total shares of Common Stock outstanding, are held by Mr. Moshe Arkin through his individual
retirement account.
|
(b) |
Percent of class:
|
(c) |
Number of shares as to which such person has:
|
(i) |
Sole power to vote or to direct the vote:
|
(ii) |
Shared power to vote or to direct the vote:
|
(iii) |
Sole power to dispose or to direct the disposition of:
|
(iv) |
Shared power to dispose or to direct the disposition of:
|
Item 5. |
Ownership of Five Percent or Less of a Class:
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another:
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company or Control Person:
|
Item 8. |
Identification and Classification of Members of the Group:
|
Item 9. |
Notice of Dissolution of Group:
|
Arkin Bio Ventures Limited Partnership
|
|
By its General Partner,
Arkin Bio Venture Partners, Ltd.
|
|
/s/ Moshe Arkin
|
|
Name: Moshe Arkin
Title: Director
|
|
Arkin Bio Venture Partners, Ltd.
|
|
/s/ Moshe Arkin
|
|
Name: Moshe Arkin
Title: Director
|
|
/s/ Moshe Arkin
|
|
Moshe Arkin
|
1 Year Oncorus Chart |
1 Month Oncorus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions